Progressive supranuclear palsy (PSP) is a debilitating neurodegenerative disease characterized by progressive deterioration of motor control. Patients with PSP often face significant difficulties in performing everyday tasks. These restrictions can encompass walking, balance, swallowing, and speech, profoundly impacting quality of life. Rehabilitat

In randomized controlled trials, there are two treatment choices at present viewed as the normal of care in Guillain-Barré syndrome (GBS). These involve either intravenous immunoglobulin (IVIG) or plasma Trade. IVIG is believed to act by its immune-modulating action; on the other hand, the precise mechanism continues to be for being elucidated. I